Any feedback?
Literature summary extracted from
- IMP dehydrogenase: Structure, mechanism, and inhibition (2009), Chem. Rev., 109, 2903-2928.
Application
| EC Number | Application | Comment | Organism |
|---|---|---|---|
| 1.1.1.205 | drug development | IMPDH2 is the major target for cancer chemotherapy | Homo sapiens |
Cloned(Commentary)
| EC Number | Cloned (Comment) | Organism |
|---|---|---|
| 1.1.1.205 | - |
Cricetulus griseus |
| 1.1.1.205 | - |
Escherichia coli |
| 1.1.1.205 | - |
Pyrococcus horikoshii |
| 1.1.1.205 | - |
Toxoplasma gondii |
| 1.1.1.205 | - |
Streptococcus pyogenes |
| 1.1.1.205 | - |
Pneumocystis carinii |
| 1.1.1.205 | - |
Borreliella burgdorferi |
| 1.1.1.205 | expressed in Escherichia coli | Homo sapiens |
| 1.1.1.205 | expressed in Escherichia coli | Tritrichomonas suis |
| 1.1.1.205 | expressed in Escherichia coli | Cryptosporidium parvum |
Crystallization (Commentary)
| EC Number | Crystallization (Comment) | Organism |
|---|---|---|
| 1.1.1.205 | tetramer structure of IMPDH shows square planar geometry | Streptococcus pyogenes |
Protein Variants
| EC Number | Protein Variants | Comment | Organism |
|---|---|---|---|
| 1.1.1.205 | D226N | IMPDH1 polymorphism, which is associated with retinal degeneration | Homo sapiens |
| 1.1.1.205 | D301N | IMPDH1 polymorphism, which does not affect protein function | Homo sapiens |
| 1.1.1.205 | G324D | IMPDH1 polymorphism, which does not affect protein function | Homo sapiens |
| 1.1.1.205 | G519R | IMPDH1 polymorphism, which does not affect protein function | Homo sapiens |
| 1.1.1.205 | H296R | IMPDH1 polymorphism, which does not affect protein function | Homo sapiens |
| 1.1.1.205 | H372P | IMPDH1 polymorphism, which is associated with retinal degeneration | Homo sapiens |
| 1.1.1.205 | L263F | IMPDH2 polymorphism, which decreases the value of kcat by a factor of 10 | Homo sapiens |
| 1.1.1.205 | N198K | IMPDH1 polymorphism, which is associated with retinal degeneration and with Leber congenital amaurosis | Homo sapiens |
| 1.1.1.205 | R105W | IMPDH1 polymorphism, which is associated with retinal degeneration and with Leber congenital amaurosis | Homo sapiens |
| 1.1.1.205 | R224P | IMPDH1 polymorphism, which is associated with retinal degeneration | Homo sapiens |
| 1.1.1.205 | R231P | IMPDH1 polymorphism, which causes autosomal dominant retinitis pigmentosa | Homo sapiens |
| 1.1.1.205 | T116M | IMPDH1 polymorphism, which is associated with retinal degeneration | Homo sapiens |
| 1.1.1.205 | V268I | IMPDH1 polymorphism, which is associated with retinal degeneration | Homo sapiens |
Inhibitors
| EC Number | Inhibitors | Comment | Organism | Structure |
|---|---|---|---|---|
| 1.1.1.205 | (2E)-3-furan-2-yl-N-[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]prop-2-enamide | - |
Homo sapiens |  |
| 1.1.1.205 | 1,4-dimethyl-6-nitro-2H-cyclopenta[d]pyridazine | - |
Homo sapiens | |
| 1.1.1.205 | 1-(benzyloxy)-3-(3-pyridin-4-yl-1H-indol-6-yl)urea | - |
Homo sapiens | |
| 1.1.1.205 | 1-methyl-6-[(5-phenyl-1,3-oxazol-2-yl)amino]-1H-indole-3-carbonitrile | - |
Homo sapiens | |
| 1.1.1.205 | 1H-naphtho[2,3-d]imidazol-2-ylmethyl 4-aminobenzoate | binds in the nicotinamide subsite and does not interact with ADP | Cryptosporidium parvum | |
| 1.1.1.205 | 2-(1-benzothiophen-3-yl)-6-methoxy-5-(1,3-oxazol-5-yl)-1H-indole-3-carbaldehyde | - |
Homo sapiens | |
| 1.1.1.205 | 2-[(3-ethyl-4-oxo-3,4-dihydrothieno[3,2-d]pyrimidin-2-yl)sulfanyl]-N-(4-methoxyphenyl)acetamide | antagonizes ADP binding | Cryptosporidium parvum | |
| 1.1.1.205 | 2-[2-(Z)-fluorovinyl]-inosine 5'-phosphate | is a time-dependent inactivator | Escherichia coli | |
| 1.1.1.205 | 2-[methyl[2-(2-[[3-(1,3-oxazol-5-yl)-1H-indol-6-yl]amino]-1,3-oxazol-5-yl)phenyl]amino]-2-oxoethyl acetate | - |
Homo sapiens | |
| 1.1.1.205 | 2264A | inhibits lymphocyte proliferation; inhibits lymphocyte proliferation | Homo sapiens | |
| 1.1.1.205 | 2264B | inhibits lymphocyte proliferation; inhibits lymphocyte proliferation | Homo sapiens | |
| 1.1.1.205 | 3-hydrogenkwadaphnin | - |
Homo sapiens | |
| 1.1.1.205 | 4-[[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]amino]-6-phenyl-1,3,5-triazin-2-ol | - |
Homo sapiens | |
| 1.1.1.205 | 5-bromoisoquinolin-6-amine | - |
Homo sapiens | |
| 1.1.1.205 | 5-chloro-1,4-dimethyl-2H-cyclopenta[d]pyridazine-6-carbonitrile | - |
Homo sapiens | |
| 1.1.1.205 | 6,6'-oxydi(1,4-dihydroquinoxaline-2,3-dione) | binds in the nicotinamide subsite and does not interact with ADP | Cryptosporidium parvum | |
| 1.1.1.205 | 6-chloroinosine 5'-phosphate | - |
Homo sapiens | |
| 1.1.1.205 | 6-Cl-IMP | - |
Klebsiella aerogenes | |
| 1.1.1.205 | 7-methoxy-2-(3-methylphenyl)-6-(1,3-oxazol-5-yl)quinolin-4(1H)-one | - |
Homo sapiens | |
| 1.1.1.205 | 7-methoxy-6-(1,3-oxazol-5-yl)-3-(2-pyridin-4-ylethyl)-2-thioxo-2,3-dihydroquinazolin-4(1H)-one | - |
Homo sapiens | |
| 1.1.1.205 | ADP | - |
Cryptosporidium parvum | |
| 1.1.1.205 | ADP | - |
Homo sapiens | |
| 1.1.1.205 | ADP | binds in the adenosine portion, tiazofurin and ADP are strongly synergistic inhibitors, a conformational change occurs upon the binding of one inhibitor that increases the affinity of the second inhibitor | Tritrichomonas suis | |
| 1.1.1.205 | AVN944 | induces caspase-independent apoptosis in multiple myeloma cell lines and displays antiproliferative activity against both androgen-dependent and androgen-independent prostate cancer cell lines; induces caspase-independent apoptosis in multiple myeloma cell lines and displays antiproliferative activity against both androgen-dependent and androgen-independent prostate cancer cell lines | Homo sapiens | |
| 1.1.1.205 | benzamide riboside | displays skeletal muscle toxicity in preclinical trials, which limits its utility; displays skeletal muscle toxicity in preclinical trials, which limits its utility | Homo sapiens | |
| 1.1.1.205 | beta-difluoromethylene-tiazofurin | - |
Homo sapiens | |
| 1.1.1.205 | beta-methylene-tiazofurin | - |
Homo sapiens | |
| 1.1.1.205 | blastadin 11 | - |
Homo sapiens | |
| 1.1.1.205 | EAD | - |
Escherichia coli | |
| 1.1.1.205 | EICARMP | - |
Escherichia coli | |
| 1.1.1.205 | EICARMP | - |
Homo sapiens | |
| 1.1.1.205 | eicosadienoic acid | competitive inhibitor versus IMPDH; competitive inhibitor versus IMPDH | Homo sapiens | |
| 1.1.1.205 | ethyl 9-oxo-9,10-dihydroacridine-1-carboxylate | - |
Homo sapiens | |
| 1.1.1.205 | FFAD | - |
Homo sapiens | |
| 1.1.1.205 | halicyclamine A | - |
Homo sapiens | |
| 1.1.1.205 | helenalin | - |
Homo sapiens | |
| 1.1.1.205 | imidazo[4,5-e][1,4]diazapine | fat base nucleotide, inosine 5'-phosphate but not NAD+ protects against inhibition | Escherichia coli | |
| 1.1.1.205 | imidazo[4,5-e][1,4]diazapine | fat base nucleotide, inosine 5'-phosphate but not NAD+ protects against inhibition; fat base nucleotide, inosine 5'-phosphate but not NAD+ protects against inhibition | Homo sapiens | |
| 1.1.1.205 | Li+ | - |
Borreliella burgdorferi | |
| 1.1.1.205 | Li+ | - |
Escherichia coli | |
| 1.1.1.205 | linoleic acid | - |
Homo sapiens | |
| 1.1.1.205 | merimepodib | has immunosuppressive activity; has immunosuppressive activity | Homo sapiens | |
| 1.1.1.205 | methyl 3-methyl-2-oxo-1,2-dihydroquinoline-4-carboxylate | antagonizes ADP binding | Cryptosporidium parvum | |
| 1.1.1.205 | mizoribine | - |
Candida albicans | |
| 1.1.1.205 | mizoribine | - |
Eimeria tenella | |
| 1.1.1.205 | mizoribine | - |
Escherichia coli | |
| 1.1.1.205 | mizoribine | - |
Homo sapiens | |
| 1.1.1.205 | mizoribine | - |
Leishmania donovani | |
| 1.1.1.205 | mizoribine | - |
Plasmodium falciparum | |
| 1.1.1.205 | mizoribine | - |
Staphylococcus aureus | |
| 1.1.1.205 | mizoribine | - |
Tritrichomonas suis | |
| 1.1.1.205 | mizoribine | - |
Trypanosoma brucei | |
| 1.1.1.205 | additional information | IMPDH2 interacts with protein kinase B/Akt via its plekstrin homology domain, the resulting phosphorylation reduces activity | Homo sapiens | |
| 1.1.1.205 | additional information | becomes resistant to IMPDH inhibitors by rearranging its purine salvage pathways to rely on xanthine instead of hypoxanthine | Tritrichomonas suis | |
| 1.1.1.205 | Mycophenolic acid | - |
Candida albicans | |
| 1.1.1.205 | Mycophenolic acid | - |
Eimeria tenella | |
| 1.1.1.205 | Mycophenolic acid | - |
Homo sapiens | |
| 1.1.1.205 | Mycophenolic acid | - |
Leishmania donovani | |
| 1.1.1.205 | Mycophenolic acid | - |
Plasmodium falciparum | |
| 1.1.1.205 | Mycophenolic acid | - |
Staphylococcus aureus | |
| 1.1.1.205 | Mycophenolic acid | - |
Tritrichomonas suis | |
| 1.1.1.205 | Mycophenolic acid | - |
Trypanosoma brucei | |
| 1.1.1.205 | N-(4-chlorophenyl)-2-phenoxypropanamide | antagonizes ADP binding | Cryptosporidium parvum | |
| 1.1.1.205 | N-(4-methoxyphenyl)-2-(3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)acetamide | binds in the nicotinamide subsite and does not interact with ADP | Cryptosporidium parvum | |
| 1.1.1.205 | N-(4-methoxyphenyl)-2-naphthalen-1-ylacetamide | binds in the nicotinamide subsite and does not interact with ADP | Cryptosporidium parvum | |
| 1.1.1.205 | N-(4-methoxyphenyl)-2-[2-(1,3-thiazol-4-yl)-1H-benzimidazol-1-yl]acetamide | binds in the nicotinamide subsite and does not interact with ADP | Cryptosporidium parvum | |
| 1.1.1.205 | N-(5-phenyl-1,3-oxazol-2-yl)isoquinolin-6-amine | - |
Homo sapiens | |
| 1.1.1.205 | N-[(Z)-(pyridin-3-ylimino)methyl]-2,3-dihydro-1,4-benzodioxine-2-carboxamide | - |
Cryptosporidium parvum | |
| 1.1.1.205 | N-[1-[6-(4-ethylpiperazin-1-yl)pyridin-3-yl]-1-methylethyl]-2-fluoro-9-oxo-9,10-dihydroacridine-3-carboxamide | - |
Homo sapiens | |
| 1.1.1.205 | N-[2-(2-[[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]amino]-1,3-oxazol-5-yl)phenyl]-N-methyl-2-morpholin-4-ylacetamide | - |
Homo sapiens | |
| 1.1.1.205 | N-[2-(hydroxymethyl)cyclopentyl]-N'-[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]propanediamide | - |
Homo sapiens | |
| 1.1.1.205 | Na+ | - |
Borreliella burgdorferi | |
| 1.1.1.205 | Na+ | - |
Escherichia coli | |
| 1.1.1.205 | pellynic acid | - |
Homo sapiens | |
| 1.1.1.205 | phenyl N'-cyano-N-(3-[cyano[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]carbamimidamido]benzyl)imidocarbamate | - |
Homo sapiens | |
| 1.1.1.205 | ribavirin | - |
Homo sapiens | |
| 1.1.1.205 | ribavirin | - |
Tritrichomonas suis | |
| 1.1.1.205 | Selenazofurin | - |
Homo sapiens | |
| 1.1.1.205 | SFAD | - |
Homo sapiens | |
| 1.1.1.205 | tert-butyl methyl (1S,4S)-7'-methoxy-3'-methyl-6'-(1,3-oxazol-5-yl)-4'-oxo-3',4'-dihydro-1'H-spiro[cyclopentane-1,2'-quinazoline]-3,4-dicarboxylate | - |
Homo sapiens | |
| 1.1.1.205 | TFAD | - |
Homo sapiens | |
| 1.1.1.205 | tiazofurin | - |
Cryptosporidium parvum | |
| 1.1.1.205 | tiazofurin | - |
Homo sapiens | |
| 1.1.1.205 | tiazofurin | binds in the nicotinamide portion of the dinucleotide site, tiazofurin and ADP are strongly synergistic inhibitors, a conformational change occurs upon the binding of one inhibitor that increases the affinity of the second inhibitor | Tritrichomonas suis | |
| 1.1.1.205 | VX-148 | has immunosuppressive activity; has immunosuppressive activity | Homo sapiens | |
Metals/Ions
| EC Number | Metals/Ions | Comment | Organism | Structure |
|---|---|---|---|---|
| 1.1.1.205 | Cs+ | activates | Escherichia coli | |
| 1.1.1.205 | Cs+ | activates | Borreliella burgdorferi | |
| 1.1.1.205 | K+ | - |
Streptococcus pyogenes | |
| 1.1.1.205 | K+ | activates | Escherichia coli | |
| 1.1.1.205 | K+ | activates | Homo sapiens | |
| 1.1.1.205 | K+ | activates | Tritrichomonas suis | |
| 1.1.1.205 | K+ | activates | Borreliella burgdorferi | |
| 1.1.1.205 | additional information | Li+ has no effect on activity of IMPDH2 | Homo sapiens | |
| 1.1.1.205 | additional information | Na+ has no effect on activity | Cryptosporidium parvum | |
| 1.1.1.205 | Na+ | activates | Homo sapiens | |
| 1.1.1.205 | Na+ | activates | Tritrichomonas suis | |
| 1.1.1.205 | NH4+ | activates | Escherichia coli | |
| 1.1.1.205 | NH4+ | activates | Homo sapiens | |
| 1.1.1.205 | NH4+ | activates | Borreliella burgdorferi | |
| 1.1.1.205 | Rb+ | activates | Homo sapiens | |
| 1.1.1.205 | Tl+ | activates | Homo sapiens | |
Organism
| EC Number | Organism | UniProt | Comment | Textmining |
|---|---|---|---|---|
| 1.1.1.205 | Borreliella burgdorferi | P49058 | - |
- |
| 1.1.1.205 | Candida albicans | - |
- |
- |
| 1.1.1.205 | Cricetulus griseus | - |
Chinese hamster type 2 | - |
| 1.1.1.205 | Cryptosporidium parvum | Q8T6T2 | - |
- |
| 1.1.1.205 | Eimeria tenella | - |
- |
- |
| 1.1.1.205 | Escherichia coli | - |
- |
- |
| 1.1.1.205 | Homo sapiens | P12268 | - |
- |
| 1.1.1.205 | Homo sapiens | P20839 | - |
- |
| 1.1.1.205 | Klebsiella aerogenes | - |
- |
- |
| 1.1.1.205 | Leishmania donovani | P21620 | - |
- |
| 1.1.1.205 | no activity in Giardia lamblia | - |
- |
- |
| 1.1.1.205 | no activity in Trichomonas vaginalis | - |
- |
- |
| 1.1.1.205 | Plasmodium falciparum | - |
- |
- |
| 1.1.1.205 | Pneumocystis carinii | Q12658 | - |
- |
| 1.1.1.205 | Pyrococcus horikoshii | - |
- |
- |
| 1.1.1.205 | Staphylococcus aureus | - |
- |
- |
| 1.1.1.205 | Streptococcus pyogenes | P0C0H6 | - |
- |
| 1.1.1.205 | Toxoplasma gondii | - |
- |
- |
| 1.1.1.205 | Tritrichomonas suis | P50097 | - |
- |
| 1.1.1.205 | Trypanosoma brucei | P50098 | - |
- |
Source Tissue
| EC Number | Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|---|
| 1.1.1.205 | myeloma cell | - |
Homo sapiens | - |
| 1.1.1.205 | peripheral blood mononuclear cell | - |
Homo sapiens | - |
| 1.1.1.205 | prostate cancer cell | - |
Homo sapiens | - |
| 1.1.1.205 | retina | - |
Homo sapiens | - |
| 1.1.1.205 | retina | IMPDH1 predominates in the adult retina | Homo sapiens | - |
| 1.1.1.205 | spleen | - |
Homo sapiens | - |
Substrates and Products (Substrate)
| EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|---|
| 1.1.1.205 | inosine 5'-phosphate + NAD+ + H2O | - |
Cricetulus griseus | xanthosine 5'-phosphate + NADH + H+ | - |
? | |
| 1.1.1.205 | inosine 5'-phosphate + NAD+ + H2O | - |
Staphylococcus aureus | xanthosine 5'-phosphate + NADH + H+ | - |
? | |
| 1.1.1.205 | inosine 5'-phosphate + NAD+ + H2O | - |
Escherichia coli | xanthosine 5'-phosphate + NADH + H+ | - |
? | |
| 1.1.1.205 | inosine 5'-phosphate + NAD+ + H2O | - |
Klebsiella aerogenes | xanthosine 5'-phosphate + NADH + H+ | - |
? | |
| 1.1.1.205 | inosine 5'-phosphate + NAD+ + H2O | - |
Candida albicans | xanthosine 5'-phosphate + NADH + H+ | - |
? | |
| 1.1.1.205 | inosine 5'-phosphate + NAD+ + H2O | - |
Plasmodium falciparum | xanthosine 5'-phosphate + NADH + H+ | - |
? | |
| 1.1.1.205 | inosine 5'-phosphate + NAD+ + H2O | - |
Eimeria tenella | xanthosine 5'-phosphate + NADH + H+ | - |
? | |
| 1.1.1.205 | inosine 5'-phosphate + NAD+ + H2O | - |
Pyrococcus horikoshii | xanthosine 5'-phosphate + NADH + H+ | - |
? | |
| 1.1.1.205 | inosine 5'-phosphate + NAD+ + H2O | - |
Homo sapiens | xanthosine 5'-phosphate + NADH + H+ | - |
? | |
| 1.1.1.205 | inosine 5'-phosphate + NAD+ + H2O | - |
Tritrichomonas suis | xanthosine 5'-phosphate + NADH + H+ | - |
? | |
| 1.1.1.205 | inosine 5'-phosphate + NAD+ + H2O | - |
Cryptosporidium parvum | xanthosine 5'-phosphate + NADH + H+ | - |
? | |
| 1.1.1.205 | inosine 5'-phosphate + NAD+ + H2O | - |
Leishmania donovani | xanthosine 5'-phosphate + NADH + H+ | - |
? | |
| 1.1.1.205 | inosine 5'-phosphate + NAD+ + H2O | - |
Trypanosoma brucei | xanthosine 5'-phosphate + NADH + H+ | - |
? | |
| 1.1.1.205 | inosine 5'-phosphate + NAD+ + H2O | - |
Streptococcus pyogenes | xanthosine 5'-phosphate + NADH + H+ | - |
? | |
| 1.1.1.205 | inosine 5'-phosphate + NAD+ + H2O | - |
Pneumocystis carinii | xanthosine 5'-phosphate + NADH + H+ | - |
? | |
| 1.1.1.205 | inosine 5'-phosphate + NAD+ + H2O | - |
Borreliella burgdorferi | xanthosine 5'-phosphate + NADH + H+ | - |
? | |
| 1.1.1.205 | additional information | the CBS subdomain of IMPDH coordinately regulates the adenine and guanine nucleotide pool | Escherichia coli | ? | - |
? | |
Subunits
| EC Number | Subunits | Comment | Organism |
|---|---|---|---|
| 1.1.1.205 | tetramer | crystallography | Streptococcus pyogenes |
Synonyms
| EC Number | Synonyms | Comment | Organism |
|---|---|---|---|
| 1.1.1.205 | IMPDH | - |
Cricetulus griseus |
| 1.1.1.205 | IMPDH | - |
Staphylococcus aureus |
| 1.1.1.205 | IMPDH | - |
Escherichia coli |
| 1.1.1.205 | IMPDH | - |
Klebsiella aerogenes |
| 1.1.1.205 | IMPDH | - |
Candida albicans |
| 1.1.1.205 | IMPDH | - |
Plasmodium falciparum |
| 1.1.1.205 | IMPDH | - |
Eimeria tenella |
| 1.1.1.205 | IMPDH | - |
Pyrococcus horikoshii |
| 1.1.1.205 | IMPDH | - |
Toxoplasma gondii |
| 1.1.1.205 | IMPDH | - |
Tritrichomonas suis |
| 1.1.1.205 | IMPDH | - |
Cryptosporidium parvum |
| 1.1.1.205 | IMPDH | - |
Leishmania donovani |
| 1.1.1.205 | IMPDH | - |
Trypanosoma brucei |
| 1.1.1.205 | IMPDH | - |
Streptococcus pyogenes |
| 1.1.1.205 | IMPDH | - |
Pneumocystis carinii |
| 1.1.1.205 | IMPDH | - |
Borreliella burgdorferi |
| 1.1.1.205 | IMPDH1 | - |
Homo sapiens |
| 1.1.1.205 | IMPDH2 | - |
Homo sapiens |
| 1.1.1.205 | inosine 5'-monophosphate dehydrogenase | - |
Cricetulus griseus |
| 1.1.1.205 | inosine 5'-monophosphate dehydrogenase | - |
Staphylococcus aureus |
| 1.1.1.205 | inosine 5'-monophosphate dehydrogenase | - |
Escherichia coli |
| 1.1.1.205 | inosine 5'-monophosphate dehydrogenase | - |
Klebsiella aerogenes |
| 1.1.1.205 | inosine 5'-monophosphate dehydrogenase | - |
Candida albicans |
| 1.1.1.205 | inosine 5'-monophosphate dehydrogenase | - |
Plasmodium falciparum |
| 1.1.1.205 | inosine 5'-monophosphate dehydrogenase | - |
Eimeria tenella |
| 1.1.1.205 | inosine 5'-monophosphate dehydrogenase | - |
Pyrococcus horikoshii |
| 1.1.1.205 | inosine 5'-monophosphate dehydrogenase | - |
Toxoplasma gondii |
| 1.1.1.205 | inosine 5'-monophosphate dehydrogenase | - |
Homo sapiens |
| 1.1.1.205 | inosine 5'-monophosphate dehydrogenase | - |
Tritrichomonas suis |
| 1.1.1.205 | inosine 5'-monophosphate dehydrogenase | - |
Cryptosporidium parvum |
| 1.1.1.205 | inosine 5'-monophosphate dehydrogenase | - |
Leishmania donovani |
| 1.1.1.205 | inosine 5'-monophosphate dehydrogenase | - |
Trypanosoma brucei |
| 1.1.1.205 | inosine 5'-monophosphate dehydrogenase | - |
Streptococcus pyogenes |
| 1.1.1.205 | inosine 5'-monophosphate dehydrogenase | - |
Pneumocystis carinii |
| 1.1.1.205 | inosine 5'-monophosphate dehydrogenase | - |
Borreliella burgdorferi |
Cofactor
| EC Number | Cofactor | Comment | Organism | Structure |
|---|---|---|---|---|
| 1.1.1.205 | NAD+ | - |
Cricetulus griseus | |
| 1.1.1.205 | NAD+ | - |
Staphylococcus aureus | |
| 1.1.1.205 | NAD+ | - |
Escherichia coli | |
| 1.1.1.205 | NAD+ | - |
Klebsiella aerogenes | |
| 1.1.1.205 | NAD+ | - |
Candida albicans | |
| 1.1.1.205 | NAD+ | - |
Plasmodium falciparum | |
| 1.1.1.205 | NAD+ | - |
Eimeria tenella | |
| 1.1.1.205 | NAD+ | - |
Pyrococcus horikoshii | |
| 1.1.1.205 | NAD+ | - |
Homo sapiens | |
| 1.1.1.205 | NAD+ | - |
Tritrichomonas suis | |
| 1.1.1.205 | NAD+ | - |
Cryptosporidium parvum | |
| 1.1.1.205 | NAD+ | - |
Leishmania donovani | |
| 1.1.1.205 | NAD+ | - |
Trypanosoma brucei | |
| 1.1.1.205 | NAD+ | - |
Streptococcus pyogenes | |
| 1.1.1.205 | NAD+ | - |
Pneumocystis carinii | |
| 1.1.1.205 | NAD+ | - |
Borreliella burgdorferi | |
Ki Value [mM]
| EC Number | Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
|---|---|---|---|---|---|---|
| 1.1.1.205 | 0.0000005 | - |
mizoribine | - |
Escherichia coli | |
| 1.1.1.205 | 0.000001 | - |
imidazo[4,5-e][1,4]diazapine | - |
Homo sapiens | |
| 1.1.1.205 | 0.000006 | - |
VX-148 | - |
Homo sapiens | |
| 1.1.1.205 | 0.000006 | - |
AVN944 | - |
Homo sapiens | |
| 1.1.1.205 | 0.000007 | - |
merimepodib | - |
Homo sapiens | |
| 1.1.1.205 | 0.000008 | - |
mizoribine | - |
Homo sapiens | |
| 1.1.1.205 | 0.000014 | - |
VX-148 | - |
Homo sapiens | |
| 1.1.1.205 | 0.00002 | - |
Selenazofurin | with inosine 5'-phosphate as substrate | Homo sapiens | |
| 1.1.1.205 | 0.00003 | - |
Selenazofurin | with inosine 5'-phosphate as substrate | Homo sapiens | |
| 1.1.1.205 | 0.00005 | - |
imidazo[4,5-e][1,4]diazapine | IMPDH2 | Escherichia coli | |
| 1.1.1.205 | 0.00043 | - |
tiazofurin | with inosine 5'-phosphate as substrate | Homo sapiens | |
| 1.1.1.205 | 0.00043 | - |
TFAD | with inosine 5'-phosphate as substrate | Homo sapiens | |
| 1.1.1.205 | 0.00058 | - |
SFAD | with inosine 5'-phosphate as substrate | Homo sapiens | |
| 1.1.1.205 | 0.0007 | - |
tiazofurin | with inosine 5'-phosphate as substrate | Homo sapiens | |
| 1.1.1.205 | 0.0007 | - |
TFAD | with inosine 5'-phosphate as substrate | Homo sapiens | |
| 1.1.1.205 | 0.001 | - |
2-[2-(Z)-fluorovinyl]-inosine 5'-phosphate | - |
Escherichia coli | |
| 1.1.1.205 | 0.0011 | - |
SFAD | with inosine 5'-phosphate as substrate | Homo sapiens | |
| 1.1.1.205 | 0.002 | - |
EICARMP | - |
Escherichia coli | |
| 1.1.1.205 | 0.003 | - |
eicosadienoic acid | - |
Homo sapiens | |
| 1.1.1.205 | 0.016 | - |
EICARMP | - |
Homo sapiens | |
| 1.1.1.205 | 0.027 | - |
EAD | - |
Escherichia coli | |
| 1.1.1.205 | 0.038 | - |
FFAD | with inosine 5'-phosphate as substrate | Homo sapiens | |
| 1.1.1.205 | 0.056 | - |
FFAD | with inosine 5'-phosphate as substrate | Homo sapiens | |
| 1.1.1.205 | 0.078 | - |
6-chloroinosine 5'-phosphate | - |
Homo sapiens | |
| 1.1.1.205 | 0.26 | - |
6-Cl-IMP | - |
Klebsiella aerogenes | |
| 1.1.1.205 | 1.3 | - |
tiazofurin | - |
Homo sapiens | |
| 1.1.1.205 | 1.5 | - |
tiazofurin | - |
Cryptosporidium parvum | |
| 1.1.1.205 | 8.8 | - |
ADP | - |
Homo sapiens | |
| 1.1.1.205 | 31 | - |
ADP | - |
Tritrichomonas suis | |
| 1.1.1.205 | 42 | - |
ADP | - |
Cryptosporidium parvum | |
| 1.1.1.205 | 50 | - |
tiazofurin | - |
Tritrichomonas suis | |
IC50 Value
| EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
|---|---|---|---|---|---|---|
| 1.1.1.205 | 0.000005 | - |
- |
Homo sapiens | 7-methoxy-2-(3-methylphenyl)-6-(1,3-oxazol-5-yl)quinolin-4(1H)-one | |
| 1.1.1.205 | 0.000005 | - |
- |
Homo sapiens | N-(5-phenyl-1,3-oxazol-2-yl)isoquinolin-6-amine | |
| 1.1.1.205 | 0.000007 | - |
- |
Homo sapiens | 2-[methyl[2-(2-[[3-(1,3-oxazol-5-yl)-1H-indol-6-yl]amino]-1,3-oxazol-5-yl)phenyl]amino]-2-oxoethyl acetate | |
| 1.1.1.205 | 0.000012 | - |
- |
Homo sapiens | N-[2-(2-[[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]amino]-1,3-oxazol-5-yl)phenyl]-N-methyl-2-morpholin-4-ylacetamide | |
| 1.1.1.205 | 0.000013 | - |
- |
Homo sapiens | 7-methoxy-6-(1,3-oxazol-5-yl)-3-(2-pyridin-4-ylethyl)-2-thioxo-2,3-dihydroquinazolin-4(1H)-one | |
| 1.1.1.205 | 0.000016 | - |
- |
Homo sapiens | phenyl N'-cyano-N-(3-[cyano[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]carbamimidamido]benzyl)imidocarbamate | |
| 1.1.1.205 | 0.000017 | - |
- |
Homo sapiens | N-[1-[6-(4-ethylpiperazin-1-yl)pyridin-3-yl]-1-methylethyl]-2-fluoro-9-oxo-9,10-dihydroacridine-3-carboxamide | |
| 1.1.1.205 | 0.000018 | - |
- |
Homo sapiens | 4-[[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]amino]-6-phenyl-1,3,5-triazin-2-ol | |
| 1.1.1.205 | 0.000018 | - |
- |
Homo sapiens | N-[2-(hydroxymethyl)cyclopentyl]-N'-[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]propanediamide | |
| 1.1.1.205 | 0.000028 | - |
- |
Homo sapiens | (2E)-3-furan-2-yl-N-[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]prop-2-enamide | |
| 1.1.1.205 | 0.00003 | - |
- |
Homo sapiens | 2-(1-benzothiophen-3-yl)-6-methoxy-5-(1,3-oxazol-5-yl)-1H-indole-3-carbaldehyde | |
| 1.1.1.205 | 0.000033 | - |
- |
Homo sapiens | 1-methyl-6-[(5-phenyl-1,3-oxazol-2-yl)amino]-1H-indole-3-carbonitrile | |
| 1.1.1.205 | 0.000035 | - |
- |
Homo sapiens | tert-butyl methyl (1S,4S)-7'-methoxy-3'-methyl-6'-(1,3-oxazol-5-yl)-4'-oxo-3',4'-dihydro-1'H-spiro[cyclopentane-1,2'-quinazoline]-3,4-dicarboxylate | |
| 1.1.1.205 | 0.000076 | - |
- |
Homo sapiens | 1-(benzyloxy)-3-(3-pyridin-4-yl-1H-indol-6-yl)urea | |
| 1.1.1.205 | 0.0005 | - |
- |
Homo sapiens | 5-bromoisoquinolin-6-amine | |
| 1.1.1.205 | 0.00073 | - |
- |
Homo sapiens | ethyl 9-oxo-9,10-dihydroacridine-1-carboxylate | |
| 1.1.1.205 | 0.00076 | - |
- |
Homo sapiens | 5-chloro-1,4-dimethyl-2H-cyclopenta[d]pyridazine-6-carbonitrile | |
| 1.1.1.205 | 0.001 | - |
- |
Homo sapiens | pellynic acid | |
| 1.1.1.205 | 0.0019 | - |
- |
Homo sapiens | 1,4-dimethyl-6-nitro-2H-cyclopenta[d]pyridazine | |
| 1.1.1.205 | 0.07 | - |
- |
Homo sapiens | 2264A | |
General Information
| EC Number | General Information | Comment | Organism |
|---|---|---|---|
| 1.1.1.205 | physiological function | mutations in the CBS subdomain of IMPDH1 account for 2-3% of autosomal dominant retinitis pigmentosa | Homo sapiens |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
